You Searched For "takeda" and got 20 results
Sort By:
5 mins read
Takeda is buying ARIAD Pharmaceuticals in a $5.2 billion deal
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:45…
Portia Crowe
1 min read
Takeda is buying Adderall maker Shire for $64 billion in pharma's biggest deal of the year
Takeda, a 300-year-old Japanese drugmaker, has been working to expand its global footprint, most re…
Lydia Ramsey
1 min read
Takeda appoints Koki Sato as new country head for India
Takeda remains committed to serving India's patients, and aims to bring newer therapies for rare d…
PTI
1 min read
Wipro Shares Soar More Than 3% On Takeda Pharma’s Rs 2,400 Crore Deal
The deal, described as a ‘strategic partnership’ to provide IT infrastructure to the pharma company…
1 min read
A bidding war is brewing over $50 billion drugmaker Shire
Shire is known for making ADHD medicine, like Adderall and Vyvanse, and its focus on rare diseases …
Lydia Ramsey
1 min read
Takeda appoints Mahender Nayak as area head for ICMEA regions
"This is an exciting time to move to a part of the world that is teeming with great opportunities t…
PTI
3 mins read
A 237-year-old Japanese drug company just combined with a rival halfway around the world. Here's how they're confronting the challenge of merging two different cultures.
Shire, on the other hand, for years had been acquiring companies, including Baxalta for $32 billion…
Lydia Ramsey
1 min read
Takeda's considering turning up the heat on its bid for Shire
Visit Markets Insider for constantly updated market quotes for individual stocks, ETFs, indices, c…
Lydia Ramsey
3 mins read
A Japanese drug giant and a tiny New York biotech are teaming up in an unprecedented way
Dr. Jeremy Levin, Ovid's CEO, told Business Insider that this was the first time he'd seen an arran…
Lydia Ramsey
3 mins read
Meet the bankers involved in what could be a $64 billion takeover of the maker of Adderall
Evercore's team is made up of Will Hiltz, John Honts, and Julian Oakley. Hiltz is a New York-based …
Matt Turner,Lydia Ramsey
2 mins read
Japan investigating whether 3 deaths are linked to a Moderna vaccine batch that officials fear was contaminated
Moderna has said contaminants found in a separate batch do not pose a risk to health. Deaths result…
Marianne Guenot
1 min read
It looks like a key Valeant deal might be falling apart, and now the stock is tanking
The embattled pharma company had been in talks to sell the unit to Japan's Takeda for $10 billion.V…
Rachael Levy
3 mins read
This 230-year-old Japanese drugmaker is trying to transform itself into 'a 33,000 person startup'
"She basically said by all means, I would love to engage in a discussion with you about it," Villet…
Lydia Ramsey
2 mins read
STOCKS SLIP: Here's what you need to know
The S&P 500 and Dow Jones indexes both found themselves in the red, while the tech-heavy Nasdaq…
Bob Bryan
2 mins read
10 things you need to know before the opening bell
Japan's Takeda seals $62 billion takeover of Adderall maker Shire. The deal will pay Shire investor…
Jonathan Garber
4 mins read
Pharmaceutical dealmaking is starting to heat up - here's where it's headed
Specialty pharma dealmaking fell off abruptly in 2017 with just $7 billion in deals, the lowest sin…
Lydia Ramsey
3 mins read
There's still a lot of uncertainty about what Trump will do about drug prices - here's what drugmakers are doing in the meantime
Eli Lilly CEO David Ricks said that Trump's drug pricing policy didn't get discussed detail in the …
Lydia Ramsey
1 min read
What you need to know on Wall Street today
Allergan then confirmed it was "in the early stages of considering a possible offer" for Shire. Tha…
Matt Turner
1 min read
Black particles found in Moderna vaccine vial in Japan, forcing region to put shots from the batch on hold
A pharmacist in Kanagawa prefecture reportedly found several black particles in the vaccine vial on…
Natalie Musumeci
2 mins read
A new drug to treat lung cancer just got approved
The drug, made by Japanese drug giant Takeda Pharmaceuticals, is called brigatinib. It's a type of …